TiHo Bibliothek elib - Tierärztliche Hochschule Hannover

LITERATURVERZEICHNIS
EYAL, S., CHUNG, F.S., MUZI, M., LINK, J.M., MANKOFF, D.A., KADDOUMI, A., O'SULLIVAN, F.,
HEBERT, M.F., UNADKAT, J.D., 2009. Simultaneous PET Imaging of P-Glycoprotein
Inhibition in Multiple Tissues in the Pregnant Nonhuman Primate. J Nucl Med. 50: 798-806.
FALKOW, S., 1988. Molecular Koch's postulates applied to microbial pathogenicity. Rev Infect Dis. 10
Suppl 2: 274-276.
FARDEL, O., LECUREUR, V., DAVAL, S., CORLU, A., GUILLOUZO, A., 1997. Up-regulation of P-
glycoprotein expression in rat liver cells by acute treatment. Eur. J. Biochem. 246: 186-192.
FASLER-KAN, E., SUENDERHAUF, C., BARTENEVA, N., POLLER, B., GYGAX, D., HUWYLER, J.,
2010. Cytokine signaling in the human brain capillary endothelial cell line hCMEC/D3. Brain
Res. 1354: 15-22.
FDA, 2006 Food and Drug Administration (FDA) and U.S. Department of Health and Human Services,
Guidance for industry. Drug interaction studies – study design, data analysis, and implications
for dosing and labeling., http://www.fda.gov/cder/Guidance/6695dft.pdf.
FEDROWITZ, M., LÖSCHER, W., GERNERT, M., 2002: Electrophysiological investigations of the
subthalamic nucleus in the rat kindling model of epilepsy. FENS Abstract 1: A187.112.
FENG, B., MILLS, J.B., DAVIDSON, R.E., MIRELES, R.J., JANISZEWSKI, J.S., TROUTMAN, M.D.,
DE MORAIS, S.M., 2008. In vitro Pgp assays to predict the in vivo interactions of Pgp with
drugs in the central nervous system. Drug Metabol Disp 36: 268-275.
FISCHER, D.E., 1994 Apoptosis in cancer therapy: Crossing the threshold. Cell 78: 539–542.
FISHER, R.S., HO, J., 2002. Potential new methods for antiepileptic drug delivery. CNS Drugs 16:
579-593.
FISHER, R., VAN EMDE BOAS, S., BLUME, W., ELGER, C., GENTON, P., LEE, P., ENGEL, J., JR.,
2005. Epileptic seizures and epilepsy: Definitions proposed by the International League
Against Epilepsy (ILAE) and the International Bureau for Epilepsy (IBE). Epilepsia 46: 470-
472.
FORSTER, S., THUMSER, A.E., HOOD, S.R., PLANT, N., 2012. Characterization of Rhodamine-123
as a Tracer Dye for Use In In vitro Drug Transport Assays. PLoS ONE 7: e33253.
FÖRSTER, C., BUREK, M., ROMERO, I.A., WEKSLER, B., COURAUD, P.O., DRENCKHAHN, D.,
2008. Differential effects of hydrocortisone and TNFalpha on tight junction proteins in an in
vitro model of the human blood-brain barrier. J Physiol. 586: 1937-1949.
FOLDVARY, N., BINGAMAN, W., E., WYLLIE, E., 2001. Surgical treatment of epilepsy. Neurol. Clin.
19: 491-515.
FORD, J.M., HAIT, W.N., 1993. Pharmacologic circumvention of multidrug resistance. Cytotechnology.
12: 171-212.
FRANKE, H., GALLA, H.J., BEUCKMANN. C.T., 1999. An improved low-permeability in vitro-model of
the blood-brain barrier: transport studies on retinoids, sucrose, haloperidol, caffeine and
mannitol. Brain Res. 818: 65-71.
FRANKE, H., GALLA, H., BEUCKMANN, C.T., 2000. Primary cultures of brain microvessel endothelial
cells: a valid and flexible model to study drug transport through the blood-brain barrier in vitro.
Brain Res Brain Res Protoc. 5: 248-56.
186